EFPIA_欧洲障碍门户2026
聚焦EFPIA_欧洲障碍门户2026。alternative access schemes (AAS).1 On average across European countries, 69% of products have either been filed for P&R (including filed and already reimbursed) or made accessible to patients through an AAS.
聚焦EFPIA_欧洲障碍门户2026。alternative access schemes (AAS).1 On average across European countries, 69% of products have either been filed for P&R (including filed and already reimbursed) or made accessible to patients through an AAS.
聚焦EFPIA_欧洲障碍门户2026。alternative access schemes (AAS).1 On average across European countries, 69% of products have either been filed for P&R (including filed and already reimbursed) or made accessible to patients through an AAS.
聚焦EFPIA_欧洲障碍门户2026。alternative access schemes (AAS).1 On average across European countries, 69% of products have either been filed for P&R (including filed and already reimbursed) or made accessible to patients through an AAS.
覆盖 2026 年,全文共 34 页。
本报告为付费报告,可在资料宝站内下单后获取完整内容。
适合战略规划、产品经理、行业研究员等读者参考。
重点分析了EFPIA_欧洲障碍门户2026等议题。